Divas Unlimited Inc

Atlanta's Elite Fashion and Entertainment Consultants

Clostebol Acetate Powder 4-Chlorotestosterone Acetate

Clostebol acetate (alias Macrobin, Steranabol, Alfa-Trofodermin, Megagrisevit), is a synthetic,injected anabolic-androgenic steroid and a derivative of testosterone. Clostebol Acetate (turinabol)is an anabolic steroid that is derived from testosterone. Clostebol is 4-chloro-testosterone, a modification that makes this steroid a low strength anabolic compound with minimal androgenic potency. This analog of testosterone is also not 17-alpha alkylated and does not aromatize, so there is little worry of water retention, gynecomastia, or liver toxicity during use. Clostebol acetate is administered via intramuscular injection.raw dnp powder

ii. Clostebol Acetate is synthetic androgen and have a obvious gray assimilation effection,but weak in androphay effection,4-Chlorotestosterone acetate can improve synthetizing the portein ,improve appetite,improve energy. Clostebol Acetate (turinabol) does not convert to estrogen and there for estrogenic side effects such as water retention bloat and gyno aren’t a factor and the user need not worry about taking anti-estrogen compounds such as arimidex or aromasin. Clostebol acetate (turinabol) does have some stronger androgenic properties.

iii. Clostebol acetate has high anabolic action and low androgenic activity, is devoid of estrogenic properties or progestative. Clostebol acetate is used for help growth of muscle mass and strength,increased bone density and strength and stimulatie of linear growth and bone maturation. Clostebol acetate does not convert to estrogen and there for estrogenic side effects such as water retention bloat and gyno aren’t a factor and the user need not worry about taking anti-estrogen compounds such as arimidex or aromasin,it does have some stronger androgenic properties.

Views: 1

Comment

You need to be a member of Divas Unlimited Inc to add comments!

Join Divas Unlimited Inc

© 2024   Created by Diva's Unlimited Inc..   Powered by

Report an Issue  |  Terms of Service